Although there are several papers to support an oncogenic role of CLDN1 in gastric cancer, two studies nevertheless showed reduced CLDN1 staining in metastatic compared to non-metastatic gastric cancer [33], and increased tumorgenicity in CLDN1 negative gastric epithelial cells [37], contrasting our findings. This evidence concerns the gene CLDN1 and gastric cancer.